Live from the NIH registry
Studies recruiting near Winston-Salem right now
Top 25 of 601 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Wake Forest School of Medicine — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: University of Michigan
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Novant Health Forsyth Medical Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Wake Forest — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Syndax Pharmaceuticals
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Novant Health Cancer Institute — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Hoffmann-La Roche
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Atrium Health Wake Forest Baptist (Wake Forest Baptist) — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Jaeb Center for Health Research
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Greensboro, NC — Greensboro, North Carolina (26.3 mi)
· Sponsor: Mediar Therapeutics
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: AstraZeneca
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Metastatic Breast Cancer, Leptomeningeal Disease
Phase 2
Interventional 16 participants sought
Comprehensive Cancer Center at Wake Forest University (CCCWFU) — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
Gastroparesis, Idiopathic Gastric Motility Disorder
N/A
Observational 150 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Johns Hopkins Bloomberg School of Public Health
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Atrium Health Wake Forest Baptist — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Major Extremity Trauma Research Consortium
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
Novant Health Forsyth Medical Center /ID# 249533 — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: AbbVie
Remote Hypertension Management for Black Patients
Uncontrolled Hypertension
N/A
Interventional 864 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Phase 1, Phase 2
Interventional 49 participants sought
Novant Health Cancer Institute — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: ARCE Therapeutics, Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (26.3 mi)
· Sponsor: AbbVie
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
N/A
Interventional 55 participants sought
Lyndhurst Clinical Research — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Coologics, Inc
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Novant Health — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Wake Forest University - School of Medicine - Central — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Takeda
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Cone Health Cancer Center — Greensboro, North Carolina (26.3 mi)
· Sponsor: NRG Oncology
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Phase 2
Interventional 20 participants sought
Clinical Research Site — Greensboro, North Carolina (26.3 mi)
· Sponsor: Pulmovant, Inc.
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Accellacare of Winston-Salem, Triad Neurological Associates — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Ardelyx
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Medication Management — Greensboro, North Carolina (26.3 mi)
· Sponsor: Eli Lilly and Company
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Alzheimer s Disease, MCI Conversion to Dementia
N/A
Observational 1,000 participants sought
Wake Forest Baptist Medical Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Neurogen Biomarking LLC
A Clinical Study to Evaluate the Efficacy and SPF of Two Test Materials According to an Adaptation of the Guidelines of the FDA Sunscreen Drug Products for Over-the-Counter Human Use
Epidermis, Ultraviolet Exposure
Phase 4
Interventional 60 participants sought
Eurofins | CRL, Cosmetics LLC — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Good Molecules, LLC